Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Management in Head and Neck Surgery
NCT03121963Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of celecoxib oral solution, gabapentin in pain, sponsored by University of Alabama at Birmingham. Planned start Nov 2017; status: withdrawn.
02
Drugs
celecoxib oral solutiongabapentin
03
Conditions
pain
Beyond the preview
Go deeper on NCT03121963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121963.